within Pharmacolibrary.Drugs.ATC.A;

model A08AA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.73,
    Cl             = 5.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0045,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A08AA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Etilamfetamine is a synthetic stimulant of the phenethylamine and amphetamine chemical classes. It is closely related structurally to amphetamine and was used as an anorectic (anti-obesity agent) and central nervous system stimulant, but it is no longer in clinical use or approved for medical treatment in most countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical adult (approx. 70 kg) after oral administration, based on analogy to amphetamine due to lack of direct human studies.</p><h4>References</h4><ol><li><p>Paz-Ramos, MI, et al., &amp; Violante-Soria, V (2023). Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns. <i>Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion</i> 75(3) 143–157. DOI:<a href=\"https://doi.org/10.24875/RIC.23000110\">10.24875/RIC.23000110</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37441770/\">https://pubmed.ncbi.nlm.nih.gov/37441770</a></p></li><li><p>Delbeke, FT, &amp; Debackere, M (1986). The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. <i>Arzneimittel-Forschung</i> 36(9) 1413–1416. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3790195/\">https://pubmed.ncbi.nlm.nih.gov/3790195</a></p></li><li><p>Nagai, T, et al., &amp; Matsushima, K (1995). Analysis of time-lapse changes of d- and l-enantiomers of racemic ethylamphetamine and stereoselective metabolism in rat urine by HPLC determination. <i>Journal of analytical toxicology</i> 19(4) 225–228. DOI:<a href=\"https://doi.org/10.1093/jat/19.4.225\">10.1093/jat/19.4.225</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8531467/\">https://pubmed.ncbi.nlm.nih.gov/8531467</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A08AA06;
